NCT02479698View on ClinicalTrials.gov

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 23, 2015

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Acquired Immunodeficiency SyndromeBK Virus InfectionHuman Immunodeficiency VirusJC Virus InfectionMalignant NeoplasmMerkel Cell CarcinomaMerkel Cell Polyomavirus InfectionViral Encephalitis
Interventions
BIOLOGICAL

Allogeneic BK-specific Cytotoxic T-lymphocytes

Given IV

OTHER

Laboratory Biomarker Analysis

Correlative studies

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER